Videos
Video by Arlen Caplan, Mike Walters
WRAIR starts phase I clinical trials for new COVID-19 vaccine Dr Kayvon Modjarrad interview
Walter Reed Army Institute of Research
April 7, 2021 | 6:03
Dr Kayvon Modjarrad discusses his involvement in WRAIR's Phase I clinical trial to test WRAIR's spike ferritin nanoparticle (SpFN) vaccine at the WRAIR Clinical Trials Center. Built on a ferritin platform, the vaccine offers a flexible approach to targeting multiple variants of the virus that causes COVID-19 and potentially other coronaviruses as well.
More

Up Next

More Videos